Lilly Seeks First-Line KRAS Treatment with AACR Data Release
Lilly investigators said they hoped to differentiate their Phase I candidate from the competitive KRAS space by making it the first to gain approval as a first-line treatment.
Lilly Seeks First-Line KRAS Treatment with AACR Data Release Read More »
